Reply to "Do not de-escalate oncology care in oropharyngeal cancer routinely"

被引：0
|
作者：
Ilmarinen, Taru [1 ]
Keski-Santti, Harri T. [1 ]
Markkanen-Leppaenen, Mari L. [1 ]
Haapaniemi, Aaro [1 ]
Tapiovaara, Laura [1 ]
Atula, Timo [1 ]
Back, Leif [1 ]
机构：
[1] Helsinki Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Helsinki, Finland
来源：
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2020年 / 42卷 / 01期
关键词：
SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; RADIOTHERAPY; SURVIVAL;
D O I：
10.1002/hed.25959
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [31] Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE
    Suton, Petar
    Skelin, Marko
    Rakusic, Zoran
    Dokuzovic, Stjepan
    Luksic, Ivica
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (05) : 1275 - 1281
  • [32] Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE
    Petar Suton
    Marko Skelin
    Zoran Rakusic
    Stjepan Dokuzovic
    Ivica Luksic
    European Archives of Oto-Rhino-Laryngology, 2019, 276 : 1275 - 1281
  • [33] REFERRAL OF LUNG CANCER PATIENTS TO SPECIALIZED CLINICAL ONCOLOGY CARE: INSTITUTO DO CANCER DO ESTADO DE SAO PAULO 2010-2011
    Caires-Lima, Rafael
    Takahashi, Tiago K.
    Mak, Milena P.
    Roitberg, Felipe S. R.
    Teixeira, Carlos H. A.
    Mesquita, Cristiane S.
    Marini, Andrea M.
    Martins, Renata E.
    Takagaki, Tereza Y.
    Araujo, Pedro N.
    Feher, Olavo
    Hoff, Paulo M.
    De Castro, Gilberto, Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S111 - S111
  • [34] Do cancer care organizations agree on supportive oncology priorities?
    Weldon, Christine B.
    Trosman, Julia Rachel
    Berardi, Rosa
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] Analysis of hydration and antiemetics policies in preventing cisplatin-related gastrointestinal and renal toxicities in low-risk human papillomavirus positive-oropharyngeal cancer (HPV plus OPC) patients undergoing chemoradiation in De-ESCALaTE trial.
    Kong, Anthony Hee
    Mistry, Pankaj
    Evans, Mererid
    Hartley, Andrew G. J.
    Fulton-Lieuw, Tessa
    Jones, David
    Dalby, Matthew
    Gray, Alastair
    Foran, Bernadette
    Sen, Mehmet
    O'Toole, Lorcan
    Al-Booz, H.
    Dyker, Karen
    Mancebo, Rafael Moleron
    Whittaker, Stephen
    Brennan, Sinead Maire
    Cook, Audrey
    Griffin, Matthew
    Dunn, Janet
    Mehanna, Hisham Mohamed
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [36] Can We Successfully De-Escalate Axillary Surgery in Women Aged ≥ 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy?
    Regina Matar
    Andrea V. Barrio
    Varadan Sevilimedu
    Tiana Le
    Alexandra Heerdt
    Monica Morrow
    Audree Tadros
    Annals of Surgical Oncology, 2022, 29 : 2263 - 2272
  • [37] Can We Successfully De-Escalate Axillary Surgery in Women 70 Years or Older with DCIS or Early Stage HR+/HER2-Breast Cancer Undergoing Mastectomy?
    Matar, R.
    Barrio, A.
    Sevilimedu, V.
    Le, T.
    Heerdt, A.
    Morrow, M.
    Tadros, A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S45 - S45
  • [38] Clinical Oncology Society of Australia position statement on exercise in cancer care REPLY
    MEDICAL JOURNAL OF AUSTRALIA, 2019, 210 (01)
  • [39] Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
    Mirghani, Haitham
    Blanchard, Pierre
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2018, 8 : 4 - 11
  • [40] Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?
    Poggio, Francesca
    Lambertini, Matteo
    de Azambuja, Evandro
    ESMO OPEN, 2018, 3 (01)
12345